• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Significance of E2-EPF in gastric cancer

Research Project

Project/Area Number 16591355
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionThe Jikei University School of Medicine

Principal Investigator

TORIUMI Yasuo  The Jikei University School of Medicine, Lecturer, 医学部, 講師 (20217590)

Co-Investigator(Kenkyū-buntansha) ISHIBASHI Yoshio  The Jikei University School of Medicine, Lecturer, 医学部, 講師 (00246373)
TAKADA Koji  The Jikei University School of Medicine, Assistant Professor, 医学部, 助教授 (30179452)
浦島 充佳  東京慈恵会医科大学, 医学部, 講師 (80203602)
Project Period (FY) 2004 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 2005: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2004: ¥1,900,000 (Direct Cost: ¥1,900,000)
KeywordsE2-EPF / Gastric Cancer / Ubiquitin
Research Abstract

1)RT-PCR
Gastric carcinoma cell lines (MKN1,MKN45,ECC10,GT3TkB) were examined for gene expression of E2-EPF using RT-PCR. mRNA expression of E2-EPF was observed in all of them.
2)Immunoblotting
Gastric carcinoma cell lines (MKN7,MKN45,IM95) and esophageal carcinoma cell line (KYSE 50) were analyzed by SDS-PAGE, followed by immunoblotting using an anti-E2-EPF polyclonal antibody of ab4504,and AP2120a. A single band of 24kDa was present in KYSE 50 and IM95 by using ab4504. But a single band of 48kDa was present in MKN7 and MKN45 by using ab4505. Various bands of muriti-ubiquitin chain conjugated with E2-EPF were ditected in each sample by using AP2120a. These result suggested that a double quantity body of E2-EPF might be present in gastric cancer.
3)Immunohistochemistry
Using paraffin-embedded specimens from patients with gastric cancer, E2-EPF protein was detected using an anti-E2-EPF polyclonal antibody of AP2120b using a dextran polymer conjugate two step visualization system. E2-EPF was enriched on the surface of nuclei in cancer cells. E2-EPF protein expression patterns within cancerous lesions were not associated with any of the following variables : TNM classification, stage, invasion into lymphatic or blood vessels, intramural metastasis, or histologic grades of differentiation.

Report

(3 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report

URL: 

Published: 2004-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi